IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AMONG PATIENTS WITH RESOLUTION OF ENTHESITIS AND/OR DACTYLITIS: POST HOC ANALYSES FROM THE KEEPSAKE 1 AND 2 TRIALS OF RISANKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS

被引:0
|
作者
Kwatra, S. [1 ]
Khattri, S. [2 ]
Amin, A. [3 ]
Liu, R. [4 ]
Padilla, B. [4 ]
Soliman, A. M. [4 ]
Kaplan, B. [4 ]
Mcgonagle, D. [5 ,6 ]
机构
[1] Johns Hopkins Univ, Dept Dermatol, Baltimore, MD USA
[2] Mt Sinai, Dept Dermatol, New York, NY USA
[3] Northwestern Med Dermatol, Dermatol, Chicago, IL USA
[4] AbbVie, Dept Immunol, N Chicago, IL USA
[5] Univ Washington, Div Rheumatol, Seattle, WA USA
[6] Univ Leeds, Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
关键词
Spondyloarthritis; Enthesitis; Pain;
D O I
10.1136/annrheumdis-2023-eular.2790
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0957
引用
收藏
页码:1696 / 1697
页数:2
相关论文
共 17 条
  • [1] Enthesitis and Dactylitis Resolution with Risankizumab for Active Psoriatic Arthritis: Integrated Analysis of the Randomized KEEPsAKE 1 and 2 Trials
    Kwatra, Shawn G.
    Khattri, Saakshi
    Amin, Ahmad Z.
    Ranza, Roberto
    Kaplan, Blair
    Shi, Linyu
    Padilla, Byron
    Soliman, Ahmed M.
    McGonagle, Dennis
    DERMATOLOGY AND THERAPY, 2024, 14 (06) : 1517 - 1530
  • [2] Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis
    Proton Rahman
    Iain B. McInnes
    Atul Deodhar
    Georg Schett
    Phillip J. Mease
    May Shawi
    Daniel J. Cua
    Jonathan P. Sherlock
    Alexa P. Kollmeier
    Xie L. Xu
    Shihong Sheng
    Christopher T. Ritchlin
    Dennis McGonagle
    Clinical Rheumatology, 2024, 43 : 1591 - 1604
  • [3] Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis
    Rahman, Proton
    Mcinnes, Iain B.
    Deodhar, Atul
    Schett, Georg
    Mease, Phillip J.
    Shawi, May
    Cua, Daniel J.
    Sherlock, Jonathan P.
    Kollmeier, Alexa P.
    Xu, Xie L.
    Sheng, Shihong
    Ritchlin, Christopher T.
    McGonagle, Dennis
    CLINICAL RHEUMATOLOGY, 2024, 43 (05) : 1591 - 1604
  • [4] Synergistic Improvements in Synovitis, Enthesitis, and Patient-Reported Outcomes for Patients with Psoriatic Arthritis Treated with Ixekizumab in SPIRIT Trials
    Kristensen, Lars-Erik
    Mcgonagle, Dennis
    Rudwaleit, Martin
    Kameda, Hideto
    Wurtzen, Peter Adler
    Ngantcha, Marcus
    Holzkamper, Thorsten
    Smolen, Josef
    RHEUMATOLOGY AND THERAPY, 2025, 12 (02) : 381 - 395
  • [5] Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies
    Ana-Maria Orbai
    Philip J. Mease
    Philip S. Helliwell
    Oliver FitzGerald
    Dona L. Fleishaker
    Rajiv Mundayat
    Pamela Young
    BMC Rheumatology, 6
  • [6] Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies
    Orbai, Ana-Maria
    Mease, Philip J.
    Helliwell, Philip S.
    FitzGerald, Oliver
    Fleishaker, Dona L.
    Mundayat, Rajiv
    Young, Pamela
    BMC RHEUMATOLOGY, 2022, 6 (01)
  • [7] Effects of upadacitinib on enthesitis in patients with psoriatic arthritis: a post hoc analysis of SELECT-PsA 1 and 2 trials
    Cantini, Fabrizio
    Marchesoni, Antonio
    Novelli, Lucia
    Gualberti, Giuliana
    Marando, Francesca
    McDearmon-Blondell, Erin L.
    Gao, Tianming
    McGonagle, Dennis
    Salvarani, Carlo
    RHEUMATOLOGY, 2024, 63 (11) : 3146 - 3154
  • [8] Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis
    Kekow, Joern
    Moots, Robert
    Khandker, Rezaul
    Melin, Jeffrey
    Freundlich, Bruce
    Singh, Amitabh
    RHEUMATOLOGY, 2011, 50 (02) : 401 - 409
  • [9] Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1
    Strand, Vibeke
    Mease, Philip J.
    Soriano, Enrique R.
    Kishimoto, Mitsumasa
    Salvarani, Carlo
    Saffore, Christopher D.
    Zueger, Patrick
    McDearmon-Blondell, Erin
    Kato, Koji
    Gladman, Dafna D.
    RHEUMATOLOGY AND THERAPY, 2021, 8 (04) : 1789 - 1808
  • [10] Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1
    Vibeke Strand
    Philip J. Mease
    Enrique R. Soriano
    Mitsumasa Kishimoto
    Carlo Salvarani
    Christopher D. Saffore
    Patrick Zueger
    Erin McDearmon-Blondell
    Koji Kato
    Dafna D. Gladman
    Rheumatology and Therapy, 2021, 8 : 1789 - 1808